- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16:46 | XFRA ISIN CHANGE | 60 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS63008J8844 ENvue Medical Inc. 31.08.2026 US63008J8760 ENvue Medical Inc. 01.09.2026 Tausch 12:1 ► Artikel lesen | |
| Fr | ENvue Medical announces 1-for-12 reverse stock split | 6 | Investing.com | ||
| Fr | ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split | 126 | GlobeNewswire (Europe) | TYLER, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that a reverse stock split... ► Artikel lesen | |
| 19.08. | ENvue Medical: Revenue Jumps 275% As Hospital Adoption Offsets PainShield Production Shutdown | 5 | pulse2.com | ||
| ENVUE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 18.08. | ENvue Medical, Inc.: ENvue Medical Announces Exclusive UroShield Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million | 179 | GlobeNewswire (Europe) | TYLER, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical device company, today announced a new exclusive distribution agreement... ► Artikel lesen | |
| 17.08. | ENvue Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.08. | ENvue Medical secures up to $50M equity facility to fund growth plans | 3 | Seeking Alpha | ||
| 12.08. | ENvue Medical secures $50M equity financing facility | 5 | Investing.com | ||
| 12.08. | ENvue Medical, Inc.: ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions | 303 | GlobeNewswire (Europe) | TYLER, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that it has entered into... ► Artikel lesen | |
| 12.08. | ENvue Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.08. | ENvue Medical completes US manufacturing transition | 1 | Investing.com | ||
| 04.08. | ENvue Medical, Inc.: ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities | 237 | GlobeNewswire (Europe) | TYLER, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical device company, today announced it has completed the transition... ► Artikel lesen | |
| 23.07. | ENvue Medical, Inc.: ENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center | 1 | GlobeNewswire (USA) | ||
| 15.07. | ENvue Medical names new chairman, adds two directors | 5 | Investing.com | ||
| 15.07. | ENvue Medical, Inc.: ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform | 466 | GlobeNewswire (Europe) | Zeev Rotstein, M.D. Named Chairman Following Four Decades in Health System Leadership, Including 12 Years as Director General of Sheba Medical Center Zvi Joseph and Lior Buchman Join Board, Bringing... ► Artikel lesen | |
| 10.07. | ENvue Medical, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 09.07. | ENvue unveils robotic-assisted AI feeding tube automation tool | 1 | MassDevice | ||
| 09.07. | ENvue Medical stellt Prototyp für robotergestützte Ernährungssonde vor | 1 | Investing.com Deutsch | ||
| 09.07. | ENvue Medical demonstrates robotic feeding tube prototype | 3 | Investing.com | ||
| 09.07. | Envue Medical Expands AI Navigation Platform With Robotic Prototype | 1 | Benzinga.com |
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 39,130 | +0,66 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BECTON DICKINSON | 162,25 | -0,83 % | BD (Becton, Dickinson and Company): BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation | STANCE trial surpasses a key enrollment milestone, advancing the clinical evaluation of GalaFLEX LITE Scaffold and generating evidence to support its use in breast revision surgery for... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | Nugen Medical Devices Inc: Nugen issues corrective disclosure following OSC review | ||
| CERENOME | 2,405 | -5,87 % | Cerenome, Inc.: Cerenome Reports Second Quarter 2026 Financial Results and Business Update | HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics... ► Artikel lesen | |
| SPINEWAY | 0,114 | 0,00 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| CO-DIAGNOSTICS | 1,220 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| CYTOSORBENTS | 0,324 | +11,72 % | Cytosorbents Corp: CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | Highlighting Four Independent Drivers of Shareholder Value
PRINCETON, N.J., Aug. 6, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the... ► Artikel lesen | |
| LIFEWARD | 7,410 | -1,20 % | Lifeward Ltd.: Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth | Revenue increase and operating performance improve as capital-efficient distribution strategy gains momentum Strengthened balance sheet and expanding rehabilitation platform support continued commercial... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,640 | -0,27 % | Clover Health Investments, Corp.: Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 | WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great... ► Artikel lesen | |
| FULGENT GENETICS | 16,900 | -0,59 % | Fulgent expects $330M-$340M 2026 revenue as billing transition lowers collection rates | ||
| NUWELLIS, INC | 0,800 | -8,06 % | Nuwellis, Inc. - 8-K, Current Report | ||
| LOGICMARK | - | - | EQS-News: Benzinga: From "Text Me When You Get Home" To Always-On Protection: Themes Emerging Across The Evolution Of LogicMark's Aster | EQS-News: Benzinga
/ Key word(s): Healthcare
From "Text Me When You Get Home" To Always-On Protection: Themes Emerging Across The Evolution Of LogicMark's Aster 19.05.2026 / 15:05... ► Artikel lesen | |
| EMBECTA | 4,463 | +2,29 % | Dividendenbekanntmachungen (27.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDTECH AB SE0014781795 3,6 SEK 0,3243 EUR ALLIANCE WITAN PLC GB00B11V7W98 0,0733 GBP 0,0855 EUR ATMUS FILTRATION TECHNOLOGIES... ► Artikel lesen | |
| ELECTROCORE | 8,500 | 0,00 % | electroCore, Inc.: electroCore's Truvaga Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards |
ENVUE MEDICAL INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +0,57 % bei einem Aktienkurs von 0,352 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENVUE MEDICAL INC finden Sie auf Wallstreet Online.